1. Home
  2. SPRY vs BVS Comparison

SPRY vs BVS Comparison

Compare SPRY & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$6.02

Market Cap

788.5M

Sector

Health Care

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$11.85

Market Cap

783.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRY
BVS
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
788.5M
783.2M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
SPRY
BVS
Price
$6.02
$11.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$40.00
$14.00
AVG Volume (30 Days)
2.3M
706.8K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
163.46
EPS
N/A
0.04
Revenue
$84,278,000.00
$568,087,000.00
Revenue This Year
$87.40
$7.52
Revenue Next Year
$81.64
$7.06
P/E Ratio
N/A
$287.00
Revenue Growth
N/A
N/A
52 Week Low
$5.77
$5.81
52 Week High
$18.63
$12.53

Technical Indicators

Market Signals
Indicator
SPRY
BVS
Relative Strength Index (RSI) 28.16 58.18
Support Level N/A $8.04
Resistance Level $8.61 $12.53
Average True Range (ATR) 0.44 0.54
MACD -0.18 -0.07
Stochastic Oscillator 13.90 41.30

Price Performance

Historical Comparison
SPRY
BVS

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: